Sunzen Group Bhd

Sunzen Group Bhd Forward P/E

The Forward P/E Ratio of Sunzen Group Bhd (SUNZEN.KL) as of Nov 5, 2026 is 75.87. In the previous year, Forward P/E Ratio was 23.45 — a change of 223.53% (higher).

Forward P/E

75.87

YoY

223.53%

Last updated:

Forward P/E Ratio of Sunzen Group Bhd is 2025 75.87 . Forward P/E Ratio of Sunzen Group Bhd was 2024 23.45 . It decreases by 223.53% higher compared to the previous year.

The Sunzen Group Bhd Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2018
-30.55 MYR
Jan 1, 2019
-13.04 MYR
Jan 1, 2020
-16.02 MYR
Jan 1, 2021
311.66 MYR
Jan 1, 2022
56.55 MYR
Jan 1, 2023
42.89 MYR
Jan 1, 2024
23.45 MYR
Jan 1, 2025
75.87 MYR
The Sunzen Group Bhd Forward P/E history
YEARForward P/EYoY
75.87+223.53%
23.45-45.33%
42.89-24.14%
56.55-81.86%
311.66-2,045.01%
-16.02+22.84%
-13.04-57.30%
-30.55-150.07%
61.02-103.74%
-1,629.68+187.23%
-567.38—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Sunzen Group Bhd Stock analysis

What does Sunzen Group Bhd do? Sunzen Biotech Bhd. generates revenue through its four business segments: manufacturing and trading of animal health products, trading and processing of crude palm oil and related products, traditional Chinese medicines and herbal health foods and beverages, and loan financing. Its products, including bird's nest, The Joy of Life collagen drink, Pu Yao Jing tonic, essence of chicken, essence of fish, Pi Pa Gao cough syrup, and Bai Foong Wan, are sold via retail concept stores in Malaysia and the Ecolite online shop. The company's subsidiaries, such as Sunzen Corporation Sdn. Bhd. and Sunzen Lifesciences Sdn. Bhd., support these operations. Customers include consumers purchasing health and wellness products through physical stores and online platforms. The firm's animal health products segment focuses on feed supplements for animals, while the crude palm oil segment handles trading and processing of palm oil derivatives. Traditional Chinese medicine products like Pi Pa Gao cough syrup and Bai Foong Wan target health-conscious consumers. Loan financing through Finsource Credit (M) Sdn. Bhd. provides financial services to customers seeking credit solutions. Sunzen International Sdn. Bhd. likely manages international distribution of products, and Sunzen Lifesciences Sdn. Bhd. supports biotechnology research and development. The company's product portfolio spans health drinks, herbal remedies, and financial services, with sales driven by retail stores and online channels in Malaysia. Sunzen Group Bhd is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sunzen Group Bhd stock

Forward P/E Ratio of Sunzen Group Bhd is 75.87 in 2025.

Forward P/E Ratio of Sunzen Group Bhd changed from 23.45 to 75.87, representing a 223.53% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Sunzen Group Bhd since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Sunzen Group Bhd with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Sunzen Group Bhd

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Sunzen Group Bhd